Lorazepam Solution, Concentrate
Product Images NDC 0054-3532

2 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0054-3532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lorazepam Structural Formula (Image 01)

Lorazepam Structural Formula (Image 01)
Chemical structure of lorazepam, depicting its molecular bonds and arrangement including chlorine atoms, nitrogen, oxygen, and hydroxyl groups as part of its benzodiazepine chemical framework.*
FDA Label Image

Lorazepam Intensol Bottle Label Image (Image 02)

Lorazepam Intensol Bottle Label Image (Image 02)
Label for Lorazepam Intenso Oral Concentrate, USP 2 mg/mL solution, 30 mL bottle by Hikma Pharmaceuticals USA Inc. The label includes dosage strength, volume markers, storage instructions to refrigerate at 2° to 8°C, and usage directions for oral administration using a calibrated syringe. It also notes to discard the bottle after 90 days and protect from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.